In this study, Eda-Bor reduced cerebral ischemia-induced phosphorylation of ERK, JNK, and p38, thereby inhibiting MAPK-mediated apoptosis and inflammation and reducing brain damage. This evidence concerns the gene MAPK14 and brain ischemia.